Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 138

1.

Significant attenuation of macrovascular involvement by bosentan in a patient with diffuse cutaneous systemic sclerosis with multiple digital ulcers and gangrene.

Ichimura Y, Asano Y, Hatano M, Tamaki Z, Takekoshi T, Kogure A, Tomita M, Kawashima T, Miyazaki M, Taniguchi T, Takahashi T, Mitsui H, Sugaya M, Yao A, Kinugawa K, Sato S.

Mod Rheumatol. 2011 Oct;21(5):548-52. doi: 10.1007/s10165-011-0436-5. Epub 2011 Mar 10.

PMID:
21547701
2.

Bosentan for digital ulcers in patients with systemic sclerosis.

Nagai Y, Hasegawa M, Hattori T, Okada E, Tago O, Ishikawa O.

J Dermatol. 2012 Jan;39(1):48-51. doi: 10.1111/j.1346-8138.2011.01299.x. Epub 2011 Sep 28.

PMID:
21955007
3.

Digital ulcers in systemic sclerosis: prevention by treatment with bosentan, an oral endothelin receptor antagonist.

Korn JH, Mayes M, Matucci Cerinic M, Rainisio M, Pope J, Hachulla E, Rich E, Carpentier P, Molitor J, Seibold JR, Hsu V, Guillevin L, Chatterjee S, Peter HH, Coppock J, Herrick A, Merkel PA, Simms R, Denton CP, Furst D, Nguyen N, Gaitonde M, Black C.

Arthritis Rheum. 2004 Dec;50(12):3985-93.

4.

Clinical burden of digital vasculopathy in limited and diffuse cutaneous systemic sclerosis.

Nihtyanova SI, Brough GM, Black CM, Denton CP.

Ann Rheum Dis. 2008 Jan;67(1):120-3. Epub 2007 Jul 27.

PMID:
17660220
5.

[Bosentan for treatment of active digital ulcers in patients with systemic sclerosis].

Launay D, Diot E, Pasquier E, Mouthon L, Boullanger N, Fain O, Jego P, Carpentier P, Hatron PY, Hachulla E.

Presse Med. 2006 Apr;35(4 Pt 1):587-92. French.

6.

Bosentan treatment of digital ulcers related to systemic sclerosis: results from the RAPIDS-2 randomised, double-blind, placebo-controlled trial.

Matucci-Cerinic M, Denton CP, Furst DE, Mayes MD, Hsu VM, Carpentier P, Wigley FM, Black CM, Fessler BJ, Merkel PA, Pope JE, Sweiss NJ, Doyle MK, Hellmich B, Medsger TA Jr, Morganti A, Kramer F, Korn JH, Seibold JR.

Ann Rheum Dis. 2011 Jan;70(1):32-8. doi: 10.1136/ard.2010.130658. Epub 2010 Aug 30.

7.

Bosentan as a rescue therapy in scleroderma refractory digital ulcers.

Chamaillard M, Heliot-Hosten I, Constans J, Taïeb A.

Arch Dermatol. 2007 Jan;143(1):125-6. No abstract available.

PMID:
17224564
8.

Successful treatment with bosentan for refractory digital ulcers in a patient with systemic lupus erythematosus.

Nagai Y, Shimizu A, Ishikawa O.

J Dermatol. 2008 Jul;35(7):447-51. doi: 10.1111/j.1346-8138.2008.00500.x.

PMID:
18705833
9.

Arteriographic evaluation of vascular changes of the extremities in patients with systemic sclerosis.

Hasegawa M, Nagai Y, Tamura A, Ishikawa O.

Br J Dermatol. 2006 Dec;155(6):1159-64.

PMID:
17107383
10.

Bosentan for digital ulcers in patients with systemic sclerosis: a prospective 3-year followup study.

Tsifetaki N, Botzoris V, Alamanos Y, Argyriou E, Zioga A, Drosos AA.

J Rheumatol. 2009 Jul;36(7):1550-2. doi: 10.3899/jrheum.080992. No abstract available.

PMID:
19567637
11.

[Digital ulcers in systemic sclerosis : A retrospective heath service study analysing treatment with bosentan and other vasoactive therapies].

Riemekasten G, Beissert S, Distler JH, Kreuter A, Müller-Ladner U.

Z Rheumatol. 2017 Apr;76(3):228-237. doi: 10.1007/s00393-016-0177-0. German.

PMID:
27535277
12.

[Digital ulcers in a cohort of 333 scleroderma patients].

Tiso F, Favaro M, Ciprian L, Cardarelli S, Rizzo M, Tonello M, Ruffatti A, Cozzi F.

Reumatismo. 2007 Jul-Sep;59(3):215-20. Italian.

13.

[Treatment of digital ulcers in systemtic sclerosis with endothelin-1 receptor antagonist (bosentan)].

Riccardi MT, Chialà A, Lannone F, Grattagliano V, Covelli M, Lapadula G.

Reumatismo. 2007 Apr-Jun;59(2):135-9. Italian.

14.

Low occurrence of digital ulcers in scleroderma patients treated with bosentan for pulmonary arterial hypertension: a retrospective case-control study.

Cozzi F, Pigatto E, Rizzo M, Favaro M, Zanatta E, Cardarelli S, Riato L, Punzi L.

Clin Rheumatol. 2013 May;32(5):679-83. doi: 10.1007/s10067-013-2172-z. Epub 2013 Jan 24.

PMID:
23344686
15.

[Digital ulcers in systemic sclerosis: use of endotheline antagonists].

Mota J, Castellano A, Santiago F, Carvalho P, Madeira AS, Pereira De Moura JM, Nascimento Costa JM.

Acta Med Port. 2011 Sep-Oct;24(5):837-42. Epub 2011 Dec 29. Portuguese.

16.

Bosentan in systemic sclerosis.

Heresi GA, Minai OA.

Drugs Today (Barc). 2008 Jun;44(6):415-28. doi: 10.1358/dot.2008.44.6.1220138. Review.

PMID:
18596996
17.

Bosentan in clinical practice for treating digital and other ischemic ulcers in Spanish patients with systemic sclerosis: IBER-DU cohort study.

Roman Ivorra JA, Simeon CP, Alegre Sancho JJ, Egurbide MV, Castillo MJ, Lloria X, Fonollosa V.

J Rheumatol. 2011 Aug;38(8):1631-5. doi: 10.3899/jrheum.101266. Epub 2011 Jun 1.

PMID:
21632679
18.

Digital ulcers: overt vascular disease in systemic sclerosis.

Steen V, Denton CP, Pope JE, Matucci-Cerinic M.

Rheumatology (Oxford). 2009 Jun;48 Suppl 3:iii19-24. doi: 10.1093/rheumatology/kep105. Review.

PMID:
19487218
19.

Effects of bosentan on nondigital ulcers in patients with systemic sclerosis.

Taniguchi T, Asano Y, Hatano M, Tamaki Z, Tomita M, Kawashima T, Miyazaki M, Sumida H, Akamata K, Takahashi T, Ichimura Y, Toyama T, Sugita M, Noda S, Yao A, Kinugawa K, Sato S.

Br J Dermatol. 2012 Feb;166(2):417-21. doi: 10.1111/j.1365-2133.2011.10581.x. Epub 2011 Dec 5.

PMID:
21848685
20.

Systemic lupus erythematosus, complicated with refractory skin ulcers, treated successfully with bosentan.

Suzuki E, Kyozuka H, Nishida T, Kanno T, Ohira H.

Mod Rheumatol. 2009;19(4):447-51. doi: 10.1007/s10165-009-0184-y. Epub 2009 Jun 6.

PMID:
19504167

Supplemental Content

Support Center